| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 58.68B | 47.39B | 40.71B | 34.95B | 30.58B |
| Gross Profit | 25.62B | 19.52B | 17.09B | 14.15B | 12.57B |
| EBITDA | 17.18B | 13.68B | 11.46B | 9.99B | 8.55B |
| Net Income | 10.54B | 7.78B | 6.19B | 5.43B | 4.21B |
Balance Sheet | |||||
| Total Assets | 88.17B | 80.61B | 81.56B | 70.89B | 67.67B |
| Cash, Cash Equivalents and Short-Term Investments | 14.44B | 13.44B | 13.73B | 12.83B | 13.97B |
| Total Debt | 22.46B | 18.63B | 22.62B | 21.26B | 21.68B |
| Total Liabilities | 36.72B | 31.80B | 34.47B | 28.91B | 30.38B |
| Stockholders Equity | 51.45B | 48.81B | 47.09B | 41.98B | 37.29B |
Cash Flow | |||||
| Free Cash Flow | 10.32B | 8.77B | 7.42B | 3.41B | 7.43B |
| Operating Cash Flow | 10.69B | 9.75B | 8.33B | 3.73B | 7.56B |
| Investing Cash Flow | 1.97B | 534.00M | -3.67B | -1.44B | -328.00M |
| Financing Cash Flow | -11.66B | -10.57B | -3.77B | -3.44B | -1.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥234.71B | 21.22 | ― | 1.19% | 23.82% | 38.74% | |
78 Outperform | ¥860.72B | 22.25 | ― | 1.30% | 27.81% | 23.24% | |
72 Outperform | ¥31.45B | 10.94 | ― | 4.39% | 17.36% | 0.17% | |
71 Outperform | ¥22.36B | 11.42 | ― | 2.18% | ― | ― | |
63 Neutral | ¥15.51B | 23.31 | ― | ― | 19.98% | -45.53% | |
62 Neutral | ¥56.64B | 34.82 | ― | 2.96% | 11.21% | -55.71% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |